ZYBT$1.30-2.26%
Zhengye Biotechnology Holding Ltd
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: Nasdaq
Mkt Cap:$61.61M
Float & O/S:4.43M / 7.39M
Inst Own:1.4%
DilutionScan read 20 of Zhengye Biotechnology Holding Ltd's SEC filings and found 1 S-1 registration on file for ZYBT. The latest dilution event on file is a registration statement on Jan 9, 2024. Analysis updated Oct 12, 2026.
Signal8 Summary
ZYBT
Shrinking revenue, Nasdaq bid-price scare
Snapshot
Zhengye is a tiny Chinese veterinary vaccine maker whose business shrank sharply: FY 2025 revenue fell 37.6% to $17.4M, and gross margin dropped to 20.5% from 49% the prior year.
What's Happening Right Now
- : Zhengye regained compliance with Nasdaq's $1.00 minimum bid price requirement on Aug 5, 2026, after trading below $1 for 30 straight days earlier in the year; the company remains listed under ZYBT ahead of a Nov 25, 2026 deadline.
- : After unusual swings in its share price and volume, Zhengye said on Jul 29, 2026 it has no undisclosed material news that explains the activity and is cooperating with Nasdaq on the volume increase.
- : On Jul 21, 2026, Zhengye issued a statement addressing unusual trading activity in its shares, noting it does not normally comment on market rumors.
